ASTRAZENECA PLC (AZN.ST)

GB0009895292 - Common Stock

1642.5 +97 (+6.28%)

Technical Analysis

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ASTRAZENECA PLC

STO:AZN (4/25/2024, 5:24:59 PM)

1642.5

+97 (+6.28%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorN/A

GICS IndustryN/A

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap0

Shares

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

AZN.ST News

20 days ago - Daiichi SankyoENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors

2 months ago - AstraZenecaMANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA

6 months ago - Regeneron Pharmaceuticals, Inc.Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African Ancestry

7 months ago - AstraZenecaAstraZeneca advances UK clean heat and energy efficiencies with £100m commitment

10 months ago - AstraZenecaAstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health

a year ago - TempusTempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer

Stock Screener Links

Nasdaq Stockholm AB Stock Screener

Find more stocks on Nasdaq Stockholm AB

European Stock Screener

Find more stocks on the European

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the European